omics,MARCKS,

Haifei Qin1,2,3, Qinchen Lu1,2,3, Baicheng Hu1,2,3

  • 1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, PR China.

NPJ precision oncology
|March 12, 2026
PubMed
概括

化氨酸丰富的C激酶基质 (MARCKS) 通过促进免疫抑制瘤微环境,驱动肝细胞癌 (HCC) 的进展. 准MARKS可能会在HCC治疗中克服免疫逃避.